However, the role of its major effector cytokines (IL‐1B and IL‐18) and their known antagonists (IL‐1RA and IL‐18BP) in carcinogenesis or malignant transformation of IPMN remains unclear. The gene discussed is IL18; the disease is pancreatic intraductal papillary-mucinous neoplasm.